4 results about "Cartilage disorder" patented technology

The present invention relates to pharmacogenetics, more specifically to strategies involving biomarkers associated with the clinical response to a compound before or during treatment of a cartilage disorder, such as osteoarthritis. The present invention more particularly relates to the combination of JSW measurements and level of specific proteins present in the blood, serum, synovial fluid or in the urine, which can be used in strategies such as patients' enrichment in clinical trials, patients' selection strategy before or during treatment or for adapting the treatment of a patient in the frame of treatments for cartilage disorder, such as osteoarthritis.

Methods of using cell communication network factor 3 (CCN3) for the treatment of bone or cartilage disorders are provided. Also provided are methods of gene therapy, including methods of expressing CCN3 in vivo in an amount effective to promote new bone or cartilage growth. In addition, methods of screening for agonists, mimetics, and analogs of CCN3 are provided.

To provide a composition for maintaining bone and / or cartilage health, or for preventing, alleviating and / or treating bone and / or cartilage disorders.SOLUTION: There is provided a composition comprising Vitamin D and oleuropein for use to enhance the stimulation of bone formation by oleuropein, wherein the composition comprises between 800 and 1200IU of Vitamin D and between 0. 01mg and 1g of oleuropein. The composition may further comprise one or more bioactive molecules selected from the group consisting of antioxidants, anti-inflammatory compounds, fatty acids, prebiotic fibers, probiotics, glucosamine, chondroitin sulfate, minerals, trace elements and vitamins.SELECTED DRAWING: None

The present invention relates to 8-aryl-substituted and 8-heteroaryl-substituted 9H-pyrido[3,4-b]indoles of the formula (1), in which A, E, G, R1 to R6 and R10 are as defined in the claims, which stimulate chondrogenesis and cartilage matrix synthesis and can be used in the treatment of cartilage disorders and conditions in which a regeneration of damaged cartilage is desired, for example joint diseases such as osteoarthritis. The invention furthermore relates to processes for the synthesis of the compounds of the formula (I), their use as pharmaceuticals, and pharmaceutical compositions comprising them.